Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.20.2
Cover - shares
9 Months Ended
Sep. 30, 2020
Nov. 06, 2020
Cover [Abstract]    
Entity Registrant Name Sigyn Therapeutics, Inc.  
Entity Central Index Key 0001642159  
Document Type 10-Q  
Document Period End Date Sep. 30, 2020  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity File Number 333-204486  
Entity Incorporation, State or Country Code DE  
Entity Reporting Status Current Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   34,186,169
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2020